InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

PRECISION BIOSCIENCES INC

DTIL Clue Score48
United States Fiscal year ends May CIK 0001357874 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

27
Insider
Date
Role
Action
Shares
Price
Amount
J. Jefferson Smith
18 Feb 2026
Chief Research Officer
Sold on a plan
4,925
$3.84
$18.91K
Dario Scimeca
18 Feb 2026
General Counsel and Secretary
Sold on a plan
4,925
$3.84
$18.91K
John Alexander Kelly
18 Feb 2026
Chief Financial Officer
Sold on a plan
8,149
$3.84
$31.29K
Michael Amoroso
18 Feb 2026
President and CEO
Sold on a plan
20,559
$3.84
$78.95K
Michael Amoroso
22 Jan 2026
President and CEO
Sold on a plan
34,799
$4.17
$145.11K
John Alexander Kelly
21 Jan 2026
Chief Financial Officer
Sold on a plan
15,213
$4.03
$61.31K
Dario Scimeca
21 Jan 2026
General Counsel and Secretary
Sold on a plan
8,854
$4.03
$35.68K
Dario Scimeca
3 Nov 2025
General Counsel and Secretary
Sold on a plan
665
$6.49
$4.32K
John Alexander Kelly
3 Nov 2025
Chief Financial Officer
Sold on a plan
1,303
$6.49
$8.46K
John Alexander Kelly
3 Jul 2025
Chief Financial Officer
Sold on a plan
14,827
$4.26
$63.16K
Michael Amoroso
24 Mar 2025
President and CEO
Sold on a plan
964
$5.56
$5.36K
Dario Scimeca
4 Mar 2025
General Counsel and Secretary
Sold on a plan
272
$4.91
$1.34K
J. Jefferson Smith
4 Mar 2025
Chief Research Officer
Sold on a plan
154
$4.91
$756.14
J. Jefferson Smith
22 Jan 2025
Chief Research Officer
Sold on a plan
10,287
$4.79
$49.27K
Dario Scimeca
22 Jan 2025
General Counsel and Secretary
Sold on a plan
8,928
$4.79
$42.77K
Michael Amoroso
21 Jan 2025
President and CEO
Sold on a plan
36,838
$4.67
$172.03K
Dario Scimeca
4 Nov 2024
General Counsel and Secretary
Sold on a plan
588
$8.19
$4.82K
Dario Scimeca
10 Jun 2024
General Counsel and Secretary
Sold on a plan
93
$11.79
$1.10K
Dario Scimeca
2 May 2024
General Counsel and Secretary
Sold on a plan
272
$10.32
$2.81K
Alan List
22 Jan 2024
Chief Medical Officer
Sold on a plan
21,526
$0.36
$7.75K
Dario Scimeca
22 Jan 2024
General Counsel and Secretary
Sold on a plan
21,287
$0.36
$7.66K
Michael Amoroso
22 Jan 2024
President and CEO
Sold on a plan
137,390
$0.36
$49.46K
Michael Amoroso
3 Nov 2023
President and CEO
Sold on a plan
125,025
$0.40
$50.01K
Dario Scimeca
3 Nov 2023
General Counsel and Secretary
Sold on a plan
16,023
$0.40
$6.41K
Dario Scimeca
8 Jun 2023
General Counsel and Secretary
Sold on a plan
13,361
$0.75
$10.02K
Alan List
27 Apr 2023
Chief Medical Officer
Sold on a plan
7,771
$0.79
$6.14K
Michael Amoroso
22 Mar 2023
President and CEO
Sold on a plan
46,999
$0.82
$38.54K
Show all 122 transactions →

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 38
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 11,715,028
Sales filed before the plan box existed 8
History held since 29 Mar 2019